Hiring Smarter: Best Practices for Interviews: What's the Tea in L&E?
California Employment News: Gathering Information in a Workplace Investigation – Part 2 (Featured)
Compliance Tip of the Day: Risk Assessments and Internal Controls
FCPA Compliance Report: The Role of Culture and Data in Fraud Risk Management - A Conversation with Vincent Walden
Compliance Tip of the Day: Podcasting for Compliance Training
Compliance Tip of the Day: Compliance Training Frequency
Compliance Tip of the Day: Using Supply Chain to Innovate in Compliance
Innovation in Compliance: Innovative Approaches to Compliance and Training with Catherine Choe
Work This Way: A Labor & Employment Law Podcast | Episode 46: The 2025 Greenville SHRM Conference with Tyler Clark and Brittany Goforth of GSHRM
Compliance tip of the Day: Communication Through Persuasion
Compliance Tip of the Day: Middle Managers as the Eyes and Ears of Compliance
Joe Green & Monica Rodriguez Kuniyoshi on Integrating Generative AI with Your Experts - Passle CMO Series Podcast RE-RELEASE:
Compliance Tip of the Day – Role of Chatbots in Compliance
FCPA Compliance Report: Kristy Grant-Hart on A 360° Review of the Future of Compliance
Compliance Tip of the Day: Embedded Compliance
A Blueprint for Efficient SRRs: Mastering Your Subject Rights Workflow
Law School Toolbox Podcast Episode 496: The Early BigLaw Recruiting Timeline (w/Sadie Jones)
Whistleblower Challenges and Employer Responses: One-on-One with Alex Barnard
Compliance Tip of the Day: Compliance By Design
Podcast - Parting Thoughts: Be a "Peddler of Common Sense"
AGG partner and Life Science team member, Allison Raley, will present a complimentary webinar examining how life sciences companies can overcome challenges in the face of U.S. tariffs. As international trade tensions persist...more
Join the conference that the “who’s who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. ACI’s Paragraph IV Litigation Conference is returning LIVE & IN-PERSON to...more
Last week, the Food and Drug Administration (“FDA”) issued a pair of Guidance for Industry documents outlining best practices for developing proprietary names (i.e. brand names) for prescription and nonprescription human drug...more
Hear from the FDA and the leaders of the biosimilars and innovator biologics industries about the impact of the pandemic on the global IP market and gain practical guidance for what is coming down the pipeline. The novel...more
In response to growing medical product supply shortages and need for information, the US Food and Drug Administration (FDA) has recently issued multiple enforcement policies to provide guidance to industry. Here, we focus on...more
As recently as March 27, the WHO was stating on its website that there was insufficient evidence to suggest that the novel coronavirus was airborne except in a handful of medical cases, such as when intubating an infected...more
China is cautiously recovering from the peak of the COVID-19 outbreak and is moving into a new period of investor-friendly policies aimed at restarting China’s economic engine....more
To combat shortages of N95 respirators, the Centers for Disease Control and Prevention issued and continues to update its Strategies for Optimizing the Supply of N95 Respirators. The CDC’s N95 Respirator Strategies provide...more
U.S. and international health authorities continue to respond to the outbreak of the novel coronavirus (COVID-19). While originally detected in Wuhan City, Hubei Province, China, as of the date of this alert the virus has now...more